Stevanato Group (NYSE:STVN) Hits New 52-Week Low - Here's Why

Shares of Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) hit a new 52-week low on Friday . The stock traded as low as €16.30 ($17.91) and last traded at €16.30 ($17.91), with a volume of 810 shares trading hands. The stock had previously closed at €20.09 ($22.08).

Wall Street Analyst Weigh In

A number of research analysts have issued reports on STVN shares. Bank of America upped their target price on shares of Stevanato Group from $24.00 to $26.00 and gave the company a "buy" rating in a report on Friday, December 13th. UBS Group decreased their target price on shares of Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a research report on Friday, March 7th. Wolfe Research assumed coverage on Stevanato Group in a report on Friday, December 13th. They issued an "outperform" rating and a $28.00 price target for the company. Finally, William Blair restated an "outperform" rating on shares of Stevanato Group in a report on Friday, March 7th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat, Stevanato Group has an average rating of "Moderate Buy" and a consensus target price of €25.70 ($28.24).

Stevanato Group Stock Performance

The stock's 50 day simple moving average is €20.60 and its two-hundred day simple moving average is €20.60. The company has a market cap of $5.95 billion, a PE ratio of 41.83, a P/E/G ratio of 7.18 and a beta of 0.52. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22.

Remove Ads

Stevanato Group (NYSE:STVN - Get Free Report) last issued its earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share for the quarter, hitting the consensus estimate of €0.20 ($0.22). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The business had revenue of €352.68 million for the quarter, compared to analyst estimates of €346.26 million. As a group, research analysts anticipate that Stevanato Group S.p.A. will post 0.5 earnings per share for the current year.

Hedge Funds Weigh In On Stevanato Group

Hedge funds have recently made changes to their positions in the business. First Bank & Trust lifted its stake in shares of Stevanato Group by 7.3% during the fourth quarter. First Bank & Trust now owns 15,145 shares of the company's stock worth $330,000 after purchasing an additional 1,036 shares in the last quarter. Truist Financial Corp lifted its position in Stevanato Group by 4.2% during the 4th quarter. Truist Financial Corp now owns 26,900 shares of the company's stock worth $586,000 after acquiring an additional 1,073 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its holdings in Stevanato Group by 9.7% in the 4th quarter. Oppenheimer Asset Management Inc. now owns 12,874 shares of the company's stock worth $281,000 after acquiring an additional 1,141 shares during the period. US Bancorp DE grew its position in Stevanato Group by 17.9% in the fourth quarter. US Bancorp DE now owns 8,527 shares of the company's stock valued at $186,000 after acquiring an additional 1,295 shares in the last quarter. Finally, Captrust Financial Advisors raised its stake in shares of Stevanato Group by 12.7% during the third quarter. Captrust Financial Advisors now owns 13,100 shares of the company's stock valued at $262,000 after purchasing an additional 1,480 shares during the period.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.